← Eichor
Study identifier: NCT06133569 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

ReDirection - Self Help Program for Individuals with Sexual Interest in Children

Condition: Child Abuse Sexual · Pedophilia  ·  Sponsor: Karolinska Institutet

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The overall aim of the study is to evaluate the effectiveness of the ReDirection program for individuals with low or medium risk to commit child sexual abuse. Primary question: Is ReDirection a feasible, effective, and safe method in reducing low to medium risk participants' use of CSAM and related behaviors?

This description comes directly from the study's public registry record.

Talk to the study team

Christoffer Rahm, MD, PhD  ·  +46793393723  ·  christoffer.rahm@ki.se

Maria Breide  ·  +46735563825  ·  maria.breide@ki.se

Always discuss trial participation with your own doctor first.

Locations (6)

National Institute of Mental HealthKlecany, CzechiaRecruiting
Protect Children NGOHelsinki, FinlandRecruiting
[University Medical Center Hamburg-EppendorfHamburg, GermanyRecruiting
Bratislava Police AcademyBratislava, SlovakiaRecruiting
Universitat Jaume ICastelló, SpainRecruiting
Centre for psychiatry research, Region StockholmStockholm, SwedenRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06133569